News Releases

BOSTON, Feb. 24, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the following upcoming conferences:

• Truist Securities AI Symposium - Biotech & Tools on Tuesday, March 1, 2022, at 9:00 a.m. ET
• Cowen 42^nd Annual Health Care Conference 
• Fireside chat on Tuesday, March 8, 2022, at 2:10 p.m. ET
• Synthetic Biology Enabling Drug Discovery panel on Tuesday, March 8, 2022, at 3:30 p.m. ET
• HSBC Build with Bio Conference on Thursday, March 10, 2022, at 8:30 a.m. ET

Further details, webcast links, and replays of the presentations, if available, can be accessed on the company's investor relations website at https://investors.ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. For more information, visit https://www.ginkgobioworks.com/.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com

MEDIA CONTACT:

press@ginkgobioworks.com

SOURCE Ginkgo Bioworks